Climacteric Commentaries

References

• Chlebowski RT, Anderson GL, Gass M, et al. Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA 2010;304: 1684–92
   PubMed Web of Science ®Google Scholar
• Huang Y, Malone KE, Cushing-Haugen KL, Daling JR, Li CI. Relationship between menopausal symptoms and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2011;20:379–88
   PubMed Web of Science ®Google Scholar
• Rautiainen S, Akesson A, Levitan EB, et al. Multivitamin use and the risk of myocardial infarction: a population-based cohort of Swedish women. Am J Clin Nutr 2010;92: 1251–6
   PubMed Web of Science ®Google Scholar
• Galan P, Kesse-Guyot E, Czernichow S, et al. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. BMJ 2010; 341:c6273
   PubMed Web of Science ®Google Scholar
• Neuhouser ML, Wassertheil-Smoller S, Thomson C, et al. Multivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohorts. Arch Intern Med 2009;169:294–304
   PubMed Web of Science ®Google Scholar
• Howard BV, Curb JD, Eaton CB, et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative Dietary Modification Trial. Am J Clin Nutr 2010;91: 860–74
   PubMed Web of Science ®Google Scholar
• Carty CL, Kooperberg C, Neuhouser ML, et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. Am J Clin Nutr 2011;93:516–24
   PubMed Web of Science ®Google Scholar
• Goveas JS, Espeland MA, Woods NF, Wassertheil-Smoller S, Kotchen JM. Depressive symptoms and incidence of mild cognitive impairment and probable dementia in elderly women: the Women's Health Initiative Memory Study. J Am Geriatr Soc 2011;59:57–66
   PubMed Web of Science ®Google Scholar
• Wilson RS, Barnes LL, Mendes de Leon CF, et al. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology 2002;59:364–70
   PubMed Web of Science ®Google Scholar
• Irie F, Masaki KH, Petrovitch H, et al. Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: the Honolulu-Asia Aging Study. Arch Gen Psychiatry 2008;65:906–12
   PubMed Web of Science ®Google Scholar
• Bell-McGinty S, Butters MA, Meltzer CC, et al. Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration. Am J Psychiatry 2002;159: 1424–7
   PubMed Web of Science ®Google Scholar
• Goveas JS, Espeland MA, Hogan P, et al. Depressive symptoms, brain volumes and subclinical cerebrovascular disease in postmenopausal women: The Women's Health Initiative MRI Study. J Affect Disord 2011 Feb 23. Epub ahead of print
   PubMed Web of Science ®Google Scholar
• Kessing LV, Søndergård L, Forman JL, Andersen PK. Antidepressants and dementia. J Affect Disord 2009;117: 24–9
   PubMed Web of Science ®Google Scholar
• Bea JW, Zhao Q, Cauley JA, et al. Effect of hormone therapy on lean body mass, falls, and fractures: 6-year results from the Women's Health Initiative hormone trials. Menopause 2011;18:44–52
   PubMed Web of Science ®Google Scholar
• Kamel HK. Sarcopenia and aging. Nutr Rev 2003;61:157–67
   PubMed Web of Science ®Google Scholar
• Ryall JG, Schertzer JD, Lynch GS. Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness. Biogerontology 2008;9:213–28
   PubMed Web of Science ®Google Scholar
• Lang T, Streeper T, Cawthon P, et al. Sarcopenia: etiology, clinical consequences, intervention, and assessment. Osteoporos Int 2010;21:543–59
   PubMed Web of Science ®Google Scholar
• Pérez-López FR. Vitamin D and its implications for musculoskeletal health in women: an update. Maturitas 2007;58:117–37
   PubMed Web of Science ®Google Scholar
• Tzankoff SP, Norris AH. Effect of muscle mass decrease on age-related BMR changes. J Appl Physiol 1977;43:1001–6
   PubMed Web of Science ®Google Scholar
• Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998;147:755–63
   PubMed Web of Science ®Google Scholar
• Janssen I, Baumgartner RN, Ross R, et al. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 2004;159:413–21
   PubMed Web of Science ®Google Scholar
• Pérez-López FR, Chedraui P, Fernández-Alonso AM. et al. Vitamin D and aging: beyond calcium and bone metabolism. Maturitas 2011 Mar 21. Epub ahead of print
   Web of Science ®Google Scholar
• Woo JS, Derleth C, Stratton JR, et al. The influence of age, gender, and training on exercise efficiency. J Am Coll Cardiol 2006;47:1049–57
   PubMed Web of Science ®Google Scholar
• Poehlman ET, Tchernof A. Traversing the menopause: changes in energy expenditure and body composition. Coron Artery Dis 1998;9:799–803
   PubMed Web of Science ®Google Scholar
• Sipila S, Taaffe DR, Cheng S, Puolakka J, Toivanen J, Suominen H. Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled study. Clin Sci (Lond) 2001;101:147–57
   PubMed Web of Science ®Google Scholar
• Sorensen MB, Rosenfalck AM, Hojgaard L, Ottesen B. Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy. Obes Res 2001;9:622–6
   PubMedGoogle Scholar
• Dieli-Conwright CM, Spektor TM, Rice JC, et al. HRT and mRNA expression of estrogen receptor coregulators following exercise in postmenopausal women. Med Sci Sports Exerc 2010;42:422–9
   PubMed Web of Science ®Google Scholar
• Pérez-López FR. Vitamin D metabolism and cardiovascular risk factors in postmenopausal women. Maturitas 2009;62:248–62
   PubMed Web of Science ®Google Scholar
• Casson PR, Toth MJ, Johnson JV, et al. Correlation of serum androgens with anthropometric and metabolic indices in healthy, nonobese postmenopausal women. J Clin Endocrinol Metab 2010;95:4276–82
   PubMed Web of Science ®Google Scholar
• Davis SR, Moreau M, Kroll R, et al. Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med 2008;359:2005–17
   PubMed Web of Science ®Google Scholar
• Shifren JL, Braunstein GD, Simon JA, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000;343:682–8
   PubMed Web of Science ®Google Scholar
• Davis SR, Walker KZ, Strauss BJ. Effects of estradiol with and without testosterone on body composition and relationships with lipids in postmenopausal women. Menopause 2000;7:395–401
   PubMed Web of Science ®Google Scholar
• Wu FC, von Eckardstein A. Androgens and coronary artery disease. Endocrine Rev 2003;24:183–217
   PubMed Web of Science ®Google Scholar
• Davis SR. Testosterone for low libido in postmenopausal women not using systemic oestrogen therapy. Med J Aust 2009;191:134–5
   PubMed Web of Science ®Google Scholar
• Dharia S, Parker CR Jr. Adrenal androgens and aging. Semin Reprod Med 2004;22:361–8
   PubMed Web of Science ®Google Scholar
• Grimley Evans J, Malouf R, Huppert F, van Niekerk JK. et al. Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people. Cochrane Database of Systematic Reviews 2006;(4): CD006221
   PubMedGoogle Scholar
• Tchernof A, Labrie F. Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies. Eur J Endocrinol 2004;151:1–14
   PubMed Web of Science ®Google Scholar
• Talaei A, Amini M, Siavash M, Zare M. The effect of dehydroepiandrosterone on insulin resistance in patients with impaired glucose tolerance. Hormones 2010;9:326–31
   PubMedGoogle Scholar
• www.fda.gov/ohrms/dockets/ac/04/transcripts/2004-4082T1.pdf
   Google Scholar
• Bell RJ, Davison SL, Papalia MA, McKenzie DP, Davis SR. Endogenous androgen levels and cardiovascular risk profile in women across the adult life span. Menopause 2007;14: 630–8
   PubMed Web of Science ®Google Scholar